| # | Drug | Count |
|---|---|---|
| 0 | TESTOSTERONE CYPIONATE | 63 |
| 1 | HUMAN IMMUNOGLOBULIN G | 20 |
| 2 | ALBUTEROL SULFATE | 16 |
| 3 | KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI | 12 |
| 4 | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE | 12 |
| 5 | ALBUTEROL | 10 |
| 6 | TESTOSTERONE | 10 |
| 7 | TRIAMCINOLONE ACETONIDE | 10 |
| 8 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 10 |
| 9 | ACETAMINOPHEN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI | 12 | 0.1121 |
| 1 | FLUOROESTRADIOL F 18 | 2 | 0.0909 |
| 2 | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | 2 | 0.0556 |
| 3 | BOTULISM ANTITOXIN HEPTAVALENT | 5 | 0.0388 |
| 4 | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE | 12 | 0.0252 |
| 5 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION | 2 | 0.0185 |
| 6 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 3 | 0.0132 |
| 7 | TESTOSTERONE CYPIONATE | 63 | 0.0070 |
| 8 | VON WILLEBRAND FACTOR (RECOMBINANT) | 2 | 0.0064 |
| 9 | PIFLUFOLASTAT F-18 | 2 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 29 |
| 1 | Human Immunoglobulin G [EPC] | 20 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 3 | Radioactive Diagnostic Agent [EPC] | 16 |
| 4 | Benzodiazepine [EPC] | 13 |
| 5 | Androgen [EPC] | 11 |
| 6 | Proton Pump Inhibitor [EPC] | 10 |
| 7 | Estrogen [EPC] | 9 |
| 8 | GLP-1 Receptor Agonist [EPC] | 9 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Radioactive Diagnostic Agent [EPC] | 16 | 0.0051 |
| 1 | Autologous Cultured Cell [EPC] | 1 | 0.0022 |
| 2 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 3 | Human Immunoglobulin G [EPC] | 20 | 0.0009 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 5 | 0.0008 |
| 5 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 6 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Androgen [EPC] | 11 | 0.0004 |